— Know what they know.
Not Investment Advice

SSKN OTC

STRATA Skin Sciences, Inc.
1W: +0.0% 1M: +0.0% 3M: -96.2% YTD: -99.6% 1Y: -99.7% 3Y: -99.9% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 56 · $23251 mcap · 2M float · 0.529% daily turnover · Short 44% of daily vol

Balance Sheet Trends

Total Assets
$31M -15.6% ▼
5Y CAGR: -8.2%
Total Liabilities
$28M -11.5% ▼
5Y CAGR: +5.7%
Shareholders Equity
$3M -41.5% ▼
5Y CAGR: -35.4%
Cash & Investments
$8M +9.0% ▲
5Y CAGR: -5.7%
Total Debt
$16M -1.0% ▼
5Y CAGR: +8.4%
Net Debt
$8M -9.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$13M$5M$7M$7M$8M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$13M$5M$7M$7M$8M
Net Receivables$3M$4M$4M$5M$4M
Inventory$3M$6M$3M$2M$3M
Other Current Assets$0$2M$2M$2M$753K
Total Current Assets$20M$18M$16M$17M$16M
Property, Plant & Equip.$8M$8M$12M$11M$10M
Goodwill & Intangibles$19M$26M$14M$8M$5M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$216K$98K$231K$231K$231K
Total Non-Current Assets$27M$35M$26M$20M$15M
Total Assets$47M$52M$42M$36M$31M
— Liabilities —
Accounts Payable$3M$3M$3M$2M$3M
Short-Term Debt$0$0$0$0$16M
Deferred Revenue$3M$3M$2M$2M$2M
Other Current Liabilities$2M$5M$2M$3M$6M
Total Current Liabilities$13M$13M$12M$15M$27M
Long-Term Debt$7M$7M$15M$15M$688K
Other Non-Current Liab.$0$8M$2M$449K-$1M
Total Non-Current Liabilities$8M$17M$17M$17M$872K
Total Liabilities$21M$30M$29M$31M$28M
— Equity —
Common Stock$34K$35K$4K$4K$6K
Retained Earnings-$222M-$227M-$238M-$248M-$254M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$25M$22M$13M$5M$3M
Total Liabilities & Equity$47M$52M$42M$36M$31M
— Key Metrics —
Total Debt$8M$8M$16M$16M$16M
Net Debt-$5M$3M$9M$9M$8M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms